Weetabix adopts a Chinese flavour

Baring Private Equity Asia closes purchase of 40% stake in Weetabix and plans expansion in China. Loan financing largely taken up by Chinese banks.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES